Cytokinetics, IncorporatedCYTKNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank86
3Y CAGR+21.6%
5Y CAGR+29.5%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+21.6%/yr
vs +46.8%/yr prior
5Y CAGR
+29.5%/yr
Recent deceleration
Acceleration
-25.2pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
3.6x
Strong expansion
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 91.19 | -71.7% |
| 2024 | 322.69 | -72.1% |
| 2023 | 1155.58 | +2176.9% |
| 2022 | 50.75 | -2.4% |
| 2021 | 51.99 | +107.8% |
| 2020 | 25.02 | -5.4% |
| 2019 | 26.44 | +142.1% |
| 2018 | 10.92 | -52.8% |
| 2017 | 23.13 | +452.1% |
| 2016 | 4.19 | - |